PointState Capital’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

PointState Capital’s Portfolio CORV Stock Details CORV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-606,060	Closed	-$2.48M	–	141
2016 Q1	$2.48M	Buy	606,060 +6,060	+1%	+$32.4K	0.07%	74
2015 Q4	$4.87M	Hold	600,000	–	–	0.12%	66
2015 Q3	$5.06M	Buy	600,000 +287,563	+92%	+$2.65M	0.14%	62
2015 Q2	$2.94M	Hold	312,437	–	–	0.03%	119
2015 Q1	$2.89M	Buy	312,437 +62,437	+25%	+$598K	0.04%	101
2014 Q4	$2.31M	Buy	+250,000	New	+$2.1M	0.04%	99

Other funds holding CORV

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

CCP

Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIS

AlphaOne Investment Services West Chester, Pennsylvania $79.5M AUM 49.42% 1-Year Est. Return

Turner Investments Berwyn, Pennsylvania $134K AUM 49.03% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

PointState Capital's CORV Position: Q2 2016 in Review

PointState Capital sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q2 2016, closing a stake of 606,060 shares — an estimated $2.48M sold.

PointState Capital first reported a position in CORV in Q4 2014 and held it in 6 quarters. The position peaked at $5.06M in Q3 2015. 30 funds tracked by Wall St. Rank hold CORV as of Q2 2016.

PointState Capital reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q2 2016 after selling out during the quarter.
PointState Capital sold 606,060 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q2 2016, an estimated $2.48M.
PointState Capital first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q4 2014 and held it in 6 quarters.
PointState Capital's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $5.06M in Q3 2015.
30 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q2 2016.

Based on PointState Capital's 13F filing for Q2 2016, filed 15 Aug 2016.